Past, present, and future of CRISPR genome editing technologies
- PMID: 38428389
- DOI: 10.1016/j.cell.2024.01.042
Past, present, and future of CRISPR genome editing technologies
Abstract
Genome editing has been a transformative force in the life sciences and human medicine, offering unprecedented opportunities to dissect complex biological processes and treat the underlying causes of many genetic diseases. CRISPR-based technologies, with their remarkable efficiency and easy programmability, stand at the forefront of this revolution. In this Review, we discuss the current state of CRISPR gene editing technologies in both research and therapy, highlighting limitations that constrain them and the technological innovations that have been developed in recent years to address them. Additionally, we examine and summarize the current landscape of gene editing applications in the context of human health and therapeutics. Finally, we outline potential future developments that could shape gene editing technologies and their applications in the coming years.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests M.J. is a co-founder, equity holder, and member of the Scientific Advisory Board of Caribou Biosciences, Inc. M.J. is a named inventor on patents and patent applications related to CRISPR genome editing technologies.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous